Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Performance of Three Common Hepatitis C Virus (HCV) Genotyping Assays for Identification of HCV Genotype 2/1 Chimeras.

Peiffer KH, Kuhnhenn L, Stelzl E, Dietz J, Susser S, Tal AO, Finkelmeier F, Zuckerman E, Cornberg M, Barak M, Piazzolla V, Mangia A, Zeuzem S, Kessler HH, Vermehren J, Sarrazin C.

J Clin Microbiol. 2019 Jun 25;57(7). pii: e00060-19. doi: 10.1128/JCM.00060-19. Print 2019 Jul.

PMID:
31043467
2.

Multiple plastic stents versus covered metal stent for treatment of anastomotic biliary strictures after liver transplantation: a prospective, randomized, multicenter trial.

Tal AO, Finkelmeier F, Filmann N, Kylänpää L, Udd M, Parzanese I, Cantù P, Dechêne A, Penndorf V, Schnitzbauer A, Friedrich-Rust M, Zeuzem S, Albert JG.

Gastrointest Endosc. 2017 Dec;86(6):1038-1045. doi: 10.1016/j.gie.2017.03.009. Epub 2017 Mar 14.

PMID:
28302527
3.

Colon capsule endoscopy: current status and future directions.

Tal AO, Vermehren J, Albert JG.

World J Gastroenterol. 2014 Nov 28;20(44):16596-602. doi: 10.3748/wjg.v20.i44.16596. Review.

4.

The capsule endoscopy "suspected blood indicator" (SBI) for detection of active small bowel bleeding: no active bleeding in case of negative SBI.

Tal AO, Filmann N, Makhlin K, Hausmann J, Friedrich-Rust M, Herrmann E, Zeuzem S, Albert JG.

Scand J Gastroenterol. 2014 Sep;49(9):1131-5. doi: 10.3109/00365521.2014.923503. Epub 2014 Jun 2.

PMID:
24884306
5.

Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction.

Tal AO, Vermehren J, Friedrich-Rust M, Bojunga J, Sarrazin C, Zeuzem S, Trojan J, Albert JG.

World J Gastrointest Endosc. 2014 Jan 16;6(1):13-9. doi: 10.4253/wjge.v6.i1.13.

6.

Self-expandable metal stent for malignant colonic obstruction: outcome in proximal vs. left sided tumor localization.

Tal AO, Friedrich-Rust M, Bechstein WO, Woeste G, Trojan J, Zeuzem S, Sarrazin C, Albert JG.

Z Gastroenterol. 2013 Jun;51(6):551-7. doi: 10.1055/s-0032-1325564. Epub 2013 Jun 5.

PMID:
23740354
7.

Mineral and bone disease in black african hemodialysis patients: a report from senegal.

Seck SM, Dahaba M, Ka EF, Cisse MM, Gueye S, Tal AO.

Nephrourol Mon. 2012 Fall;4(4):613-6. doi: 10.5812/numonthly.4225. Epub 2012 Sep 24.

8.

Angiopoietin 2 stimulates TIE2-expressing monocytes to suppress T cell activation and to promote regulatory T cell expansion.

Coffelt SB, Chen YY, Muthana M, Welford AF, Tal AO, Scholz A, Plate KH, Reiss Y, Murdoch C, De Palma M, Lewis CE.

J Immunol. 2011 Apr 1;186(7):4183-90. doi: 10.4049/jimmunol.1002802. Epub 2011 Mar 2.

9.

Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.

Coffelt SB, Tal AO, Scholz A, De Palma M, Patel S, Urbich C, Biswas SK, Murdoch C, Plate KH, Reiss Y, Lewis CE.

Cancer Res. 2010 Jul 1;70(13):5270-80. doi: 10.1158/0008-5472.CAN-10-0012. Epub 2010 Jun 8.

10.

Switching of vascular phenotypes within a murine breast cancer model induced by angiopoietin-2.

Reiss Y, Knedla A, Tal AO, Schmidt MHH, Jugold M, Kiessling F, Burger AM, Wolburg H, Deutsch U, Plate KH.

J Pathol. 2009 Mar;217(4):571-80. doi: 10.1002/path.2484.

PMID:
19116989

Supplemental Content

Support Center